Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Mantle cell lymphoma
May 18, 2020
Triphase Accelerator and Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial of TRPH-222 in Patients with Non-Hodgkin's Lymphoma
Apr 21, 2020
U.S. FDA Approves IMBRUVICA® (ibrutinib) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Jan 27, 2020
Global B-cell Non-Hodgkin's Lymphoma Market Review 2017-2019 and Forecast 2020-2028
Jan 14, 2020
John Theurer Cancer Center Investigators Report Transformative Results of CAR T-Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Dec 09, 2019
Researchers at John Theurer Cancer Center, a Member of the Georgetown Lombardi Comprehensive Cancer Center Consortium, Participated in 46 Studies Presented at the 2019 American Society of Hematology's Annual Meeting & Exposition
Dec 08, 2019
Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting
Dec 07, 2019
Extended Follow-up Phase 3 Data Underscore Sustained Efficacy and Safety of IMBRUVICA® (ibrutinib) in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Dec 07, 2019
IMBRUVICA® (ibrutinib) Combination Therapy Data From Two Studies and Long-Term Integrated Analysis Presented at ASH 2019 Show Efficacy and Safety in First-Line Treatment of Chronic Lymphocytic Leukemia
Dec 07, 2019
More than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Survival in Patients with Mantle Cell Lymphoma (MCL) that Relapsed or Were Unresponsive to Prior Regimen
Nov 14, 2019
FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma supported by clinical trial results showing high response rate of tumor shrinkage
Nov 08, 2019
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA Seeking Approval of IMBRUVICA® (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Nov 08, 2019
BioInvent to Present BI-1206 Preclinical Data in Mantle Cell lymphoma at ASH 2019
Nov 06, 2019
Eli Lilly and Company to Present Multiple Abstracts for LOXO-305 at ASH 2019
Oct 08, 2019
Health Canada approves CALQUENCE® (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma (MCL)
Aug 21, 2019
New Fund to Assist Patients Living with Mantle Cell Lymphoma Opens at the HealthWell Foundation
Aug 11, 2019
A New Model for Lymphoma Drug Discovery
Jul 31, 2019
The mantle cell lymphoma therapeutics market at a CAGR of over 7% during the forecast period
Jul 12, 2019
Rituxan (rituximab; Biogen/Roche/Chugai/Zenyaku Kogyo) Drug Overview & Product Profiles 2016-2026
Jun 14, 2019
Regeneron CD20xCD3 Bispecific REGN1979 Shows Positive Results in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, including in CAR-T Failures
Jan 30, 2019
BioInvent Receives FDA Orphan Designation for BI-1206 for Mantle Cell Lymphoma
Page 1
››
Latest News
Mar 28, 2024
REX American Resources Reports Full Fiscal Year 2023 Net Income Per Share Attributable to REX Common...
Mar 28, 2024
Ministry of Education and Science of Ukraine and Palantir Partner to Create Safe Conditions for In-Person...
Mar 28, 2024
EIG’s MidOcean Energy Completes Acquisition of Tokyo Gas’ Interests in Portfolio of Australian Integrated LNG...
Mar 28, 2024
Durability of Sandton (RSA) Water Reservoir Provided by the Penetron System
Mar 28, 2024
Patria and Lockheed Martin signed a Memorandum of Agreement for the production and delivery of F-35 landing...
Mar 28, 2024
U.S. Air Force Selects Lockheed Martin For Program To Train Aircrews Against Adversarial Threats
Mar 28, 2024
Amish Patel Joins Sierra Space as Chief Operating Officer
Mar 28, 2024
BAE Systems receives $318 million services contract for M109 Self-Propelled Howitzers
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events